The Phoenix Mills Ltd. (PDF)
Trending Sector
Current IPOs
Closed IPOs
Listed IPOs
IPO Performers
CAGR Calculator
Adani Ports and SEZ
Alembic Pharmaceuticals Ltd. Share Price
Pharmaceuticals & DrugsAlembic Pharmaceuticals Ltd. (INR)958.8-10.4 (-1.1%) 
Exchange ScripsBSE533573NSEAPLLTDISININE901L01018
Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks
Trendline of performance -
Alembic Pharmaceuticals Ltd. Performance
Market performance
Open price969
High974.2
Volumes84492
Prev Close958.8
Low953.1
Closing date2025-06-18
Historical performance
1 Year High1303.90
3 Year High1303.90
5 Year High1303.90
1 Year Low725.20
3 Year Low462.30
5 Year Low462.30
Alembic Pharmaceuticals Ltd. Fundamentals
Company Valuation
Market Cap (₹Cr)
NaN
Face Value (₹)
P/E Ratio
Dividend Yield
N/A
Alembic Pharmaceuticals Ltd. Investment Returns
1 Year
10.5%
3 Years
33.1%
5 Years
5.6%
10 Years
56%
Alembic Pharmaceuticals Ltd. Technicals
| Indicators | Value | Signal |
|---|---|---|
| 5-DMA | 978.14 | Bearish |
| 10-DMA | 982.05 | Bearish |
| 20-DMA | 985.15 | Bearish |
| 50-DMA | 926.46 | Bullish |
| 100-DMA | 895.32 | Bullish |
| 200-DMA | 999.49 | Bearish |
Shareholding Pattern
| Field | Mar-2025 | Dec-2024 | Sep-2024 | Jun-2024 | Mar-2024 |
|---|---|---|---|---|---|
| Promoters | 27 | 26 | 26 | 26 | 26 |
| Foreign Investors | 1 | 1 | 1 | 1 | 1 |
| Domestic Investors | 26 | 25 | 25 | 25 | 25 |
| Public Investors | 91309 | 93918 | 91403 | 74803 | 76541 |
| Government | --- | --- | --- | --- | --- |
Alembic Pharmaceuticals Ltd. Financials
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
| Other Income | 479 | 290 | 30 | 505 |
| Operating Profit | 10508 | 9617 | 7111 | 9246 |
| Interest | 788 | 562 | 502 | 177 |
| Depreciation | 2786 | 2727 | 2754 | 2868 |
| Profit Before Tax | 7072 | 6318 | 3546 | 6254 |
| Consolidated Net Profit | 5834 | 6158 | 3420 | 5209 |
| Adjusted EPS | 30 | 31 | 17 | 27 |
Balance Sheet
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
| Share Capital | 393 | 393 | 393 | 393 |
| Total Reserves | 51516 | 47789 | 43312 | 51982 |
| Minority Interest | -14 | --- | --- | --- |
| Total Non-Current Liabilities | 51 | 28 | 524 | 1621 |
| Total Liabilities | 77088 | 63412 | 60637 | 72302 |
| Capital Work in Progress | 8372 | 5244 | 6013 | 22058 |
| Total Assets | 77088 | 63412 | 60637 | 72302 |
Cash Flow
Below figures are in Rs. Crores
| Particulars | Mar-2025 | Mar-2024 | Mar-2023 | Mar-2022 |
|---|---|---|---|---|
| Cash Flow from Operating Activities | 880 | 8032 | 7239 | 5523 |
| Cash Flow from Investing Activities | -5684 | -3206 | -4476 | -3720 |
| Cash Flow from Financing Activitie | 4437 | -4379 | -2620 | -2174 |
| Net Cash Inflow / Outflow | -367 | 447 | 144 | -370 |
0%
Negative
Neutral
Positive
- The stock has a PE ratio of 32.3.
- 3Y Stock Price CAGR of the stock is 10.5.
- The stock has a beta of 0.4.
- In the last financial year, the company had an EBITDA of ₹10508 Million.
- The company generated revenue of ₹66721 Million in the previous financial year.
Alembic Pharmaceuticals Ltd.
958.8-10.4 (-1.1%)
₹
Investment Amount: ₹ 1000000
Current Value: ₹ 1111652.2
No. of Shares: 1159.4
Performance:11.2%
P/L: ₹111652.2
Top Gainers
| Symbol | Change% |
|---|---|
| EMIL | 158.37(18%) |
| SILLYMONKS | 18(14%) |
| OPTIEMUS | 684.6(11%) |
| AAKASH | 9.7(11%) |
| PFOCUS | 130.98(10%) |
Similar stocks
Announcing Stock of the Month!
Live video call With Our Agent